Moreover, a tumor-suppressive effect of E3 ligase HRD1 on breast cancer was identified in our previous research [13], while the underlying mechanisms of HRD1 inhibiting breast cancer progression still need to be unraveled. Here, SYVN1 is linked to breast carcinoma.